BeStock  
Stocks › Biotechnology › PVLA

Palvella Therapeutics PVLA

US equityMarket cap rank #2653Biotechnology
$142.85 −$2.92 (-2.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $142.85 0.00%
Open$143.10
Prev close$145.77
Day range$142.22 – $148.69
Volume192.7K
Market cap$2.09B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-27.6x
CheapRich

Below its usual level · 27th percentile, 5-year average -14.3x

Price / book11.3x
CheapRich

Near the top of its 5-year range · 84th percentile, 5-year average 6.3x

#4987 of 5330 stocks by PB (1 = cheapest)

P/E over five years

-93x-57x-21x15xOct '21Feb '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$169.90
Price vs. fair value-15.9%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 11.26 – 6.35 84% (pricier than usual) #4987 of 5330 (1 = cheapest)
PE -27.57 -14.93 -14.32 27% (cheaper than usual) –
PS – 436.40 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on PVLA.

Sign in to join the discussion.

Scroll to Top